Another described mechanism in NAFLD/NASH pathogenesis is insulin resistance through hepatokines such as fetuin A, fetuin B, retinol-binding protein 4 (RBP4), and selenoprotein P [22]. The gene discussed is RBP4; the disease is metabolic dysfunction-associated steatotic liver disease.